Navigation Links
AnazaoHealth Announces Full Continued Cooperation with FDA to Promote Quality Assurance and Patient Safety
Date:3/8/2013

TAMPA, Fla., March 8, 2013 /PRNewswire/ -- Staying true to its commitment to patient safety, specialty pharmacy AnazaoHealth Corporation has announced continued investment in quality assurance measures, including full cooperation with the U.S. Food and Drug Administration (FDA) to assess and improve quality practices. The specialty pharmacy has been in the compounding pharmacy business for more than 15 years, and more than 95 percent of its business remains patient-specific.  Because it does not mass-produce medications and fills patient-specific prescriptions from licensed physicians, the pharmacy is not regulated by FDA Manufacturing Guidelines – instead adhering to USP<797> standards developed specifically for the compounding pharmacy industry and adopted into law by the Florida Board of Pharmacy.  Despite this, AnazaoHealth is fully cooperating with the FDA, who inspected AnazaoHealth alongside state agency inspectors who found no deficiencies.  The pharmacy continues to seek other internal and external audits to ensure the highest standards of quality and patient safety. 

"While the debate is being waged on what standards are most appropriate for the compounding pharmacy industry, we remain focused on promoting quality assurance of the highest standard, no matter what," said Jacob J. Beckel , chairman and CEO, AnazaoHealth.  "That is why in addition to meeting or exceeding all standards of our regulating body -- the Florida Board of Pharmacy -- we are also implementing measures above-and-beyond, including actions based on some of the observations by the FDA."

Throughout its history, AnazaoHealth has regularly sought both internal and external audits performed by industry experts to evaluate and guide its industry-leading quality assurance program, helping the company to meet and / or exceed all U
'/>"/>

SOURCE AnazaoHealth Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
2. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
3. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
4. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
5. China Botanic Pharmaceutical Inc. Announces Acceptance of its Plan of Compliance by NYSE MKT LLC
6. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
7. MiMedx Announces 2012 Results
8. CCS Medical Announces Agreement with LifeScan
9. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
10. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
11. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 ... convened in Boston on July ... in an effort to more fully exploit the potential ... applied to brain diseases. "As an established ... a responsibility to assume a leadership role - in ...
(Date:8/27/2015)... , Aug. 27, 2015  CytomX Therapeutics, Inc., ... treatment of cancer, today announced that Rachel ... company,s Board of Directors, has been appointed chief ... Eli Lilly and AstraZeneca, and also oversaw clinical ... checkpoint inhibitor, at Bristol-Myers Squibb and the development ...
(Date:8/27/2015)... Mass. , Aug. 27, 2015 Oryzon today ... Renshaw 17th Annual Global Investment Conference in New ... ORYZON will be represented by President and CEO Carlos ... Dr. Buesa will present this information on Thursday September 10, ... Floor).  The company is completing preclinical development of its ORY-2001 ...
Breaking Medicine Technology:New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4
... to Educate Women About this Common Condition, MILWAUKEE, ... at the Hyatt Regency Milwaukee hotel (333 West Kilbourn ... 7:30 pm to talk about her,experience with stress urinary ... Down There?: Breaking the Ice About SUI, a,national public ...
... Opiate-Like Side Effects For Several ... Months Following a Single Administration, SOUTH SAN FRANCISCO, Calif., ... that it has initiated a new,Phase 2 study of Adlea(TM) ... total knee replacement surgery, also called,total knee arthroplasty (TKA). Adlea ...
Cached Medicine Technology:Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 2Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 3Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery 2Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery 3Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery 4
(Date:8/27/2015)... Los Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... suggests that the helpfulness of a doctor is tied directly to the success of ... obese patients over a two year period, measured their weight loss over that period, ...
(Date:8/27/2015)... ... 27, 2015 , ... Workflow in labs has greatly benefitted ... in the last decade. New features such as multiplexing, microfluidics, and integration with ... do lab managers, technicians, and researchers find handy metrics to compare and judge ...
(Date:8/27/2015)... ... August 27, 2015 , ... Thriveology Founders, Dr. Carly Letzt Carney and Dr. ... Aging Expo in Denver, Colorado on Saturday, August 29, 2015 at the Marriott DTC, ... outlets as health authorities, and will present a two part seminar entitled, “How to ...
(Date:8/27/2015)... ... August 27, 2015 , ... About 10 ... slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds of ... a Georgia State University study. , While most people don’t develop persistent depression ...
(Date:8/27/2015)... ... August 27, 2015 , ... StayWell, a leading provider of ... is ICD-10 ready and available to all clients. All Krames Patient Education content ... are more targeted and return a more comprehensive data set of content than ...
Breaking Medicine News(10 mins):Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:StayWell announces all health content is ICD-10 ready 2Health News:StayWell announces all health content is ICD-10 ready 3
... type of anti-inflammatory drugs could be better for older ... older people to relieve arthritis symptoms. The problem is ... gastrointestinal problems. A specialized group of NSAIDs called COX-2 ... with heart complications. ,Researchers looked more closely at ...
... smoking actually helps arteries stay open following a procedure ... who conducted the study say they do not recommend ... of carbon monoxide in the blood stream may be ... ,Peripheral artery disease(PAD) is a narrowing or blockage ...
... level is a marker to help determine if a man ... prevalence of men with prostate cancer who had a PSA ... the Prostate Cancer Prevention Trial. Among 9,459 men in the ... than four or an abnormal rectal examination. For this research, ...
... shows pregnant women with asthma can reduce their risk of ... // mothers who ate oily fish, such as salmon and ... children with asthma. In fact, researchers say the more oily ... to develop asthma. Children with non-asthmatic mothers did not benefit ...
... recent study researchers say, the ancient Eastern tradition of yoga ... part in yoga classes reported better sleep quality than those ... 39 lymphoma patients who were either undergoing treatment or who ... patients were assigned to the yoga classes while the other ...
... one of the most worrisome long-term side effects of high-dose ... identify biochemical markers that might indicate which patients are at ... ,Troponin I is a protein present only in ... heart muscle injury that is used to diagnose and treat ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: